MEEDER ASSET MANAGEMENT INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$86,000
-69.2%
1,871
-63.0%
0.01%
-61.5%
Q2 2021$279,000
+9200.0%
5,061
+7933.3%
0.01%
Q1 2021$3,0000.0%630.0%0.00%
-100.0%
Q4 2020$3,000
+50.0%
630.0%0.00%
Q3 2020$2,000
-75.0%
63
-61.8%
0.00%
-100.0%
Q2 2020$8,000
+33.3%
165
-5.7%
0.00%
Q1 2020$6,000
-14.3%
175
+17.4%
0.00%
Q4 2019$7,000
+75.0%
149
+10.4%
0.00%
Q3 2019$4,000
+33.3%
135
+164.7%
0.00%
Q2 2019$3,0000.0%51
-19.0%
0.00%
Q2 2017$3,000
-40.0%
63
-30.8%
0.00%
Q1 2017$5,000
-44.4%
91
-47.1%
0.00%
-100.0%
Q3 2016$9,0001720.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders